188 related articles for article (PubMed ID: 28498637)
41. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
[TBL] [Abstract][Full Text] [Related]
42. Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells.
Behrouzfar K; Alaee M; Nourbakhsh M; Gholinejad Z; Golestani A
Cell Biochem Funct; 2017 Aug; 35(6):327-333. PubMed ID: 28845527
[TBL] [Abstract][Full Text] [Related]
43. Bone Marrow-Derived Mesenchymal Stem Cells Promoted Cutaneous Wound Healing by Regulating Keratinocyte Migration via β
Huo J; Sun S; Geng Z; Sheng W; Chen R; Ma K; Sun X; Fu X
Mol Pharm; 2018 Jul; 15(7):2513-2527. PubMed ID: 29757659
[TBL] [Abstract][Full Text] [Related]
44. β2-Adrenergic Receptor Signaling Pathway Stimulates the Migration and Invasion of Cancer Cells via Src Activation.
Jeong JH; Park HJ; Park SH; Choi YH; Chi GY
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144682
[TBL] [Abstract][Full Text] [Related]
45. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
46. TWEAK increases SIRT1 expression and promotes p53 deacetylation affecting human hepatic stellate cell senescence.
Zhang F; Zhang M; Wang A; Xu M; Wang C; Xu G; Zhang B; Zou X; Zhuge Y
Cell Biol Int; 2017 Feb; 41(2):147-154. PubMed ID: 27888541
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
[TBL] [Abstract][Full Text] [Related]
48. Sirt1 attenuates camptothecin-induced apoptosis through caspase-3 pathway in porcine preadipocytes.
Pang WJ; Xiong Y; Wang Y; Tong Q; Yang GS
Exp Cell Res; 2013 Mar; 319(5):670-83. PubMed ID: 23313858
[TBL] [Abstract][Full Text] [Related]
49. Sirtuin1 (SIRT1) in the Acetylation of Downstream Target Proteins.
Gomes AR; Yong JS; Kiew KC; Aydin E; Khongkow M; Laohasinnarong S; Lam EW
Methods Mol Biol; 2016; 1436():169-88. PubMed ID: 27246215
[TBL] [Abstract][Full Text] [Related]
50. Sirt1 overexpression suppresses fluoride-induced p53 acetylation to alleviate fluoride toxicity in ameloblasts responsible for enamel formation.
Suzuki M; Ikeda A; Bartlett JD
Arch Toxicol; 2018 Mar; 92(3):1283-1293. PubMed ID: 29185024
[TBL] [Abstract][Full Text] [Related]
51. P53 and Sirt1: routes of metabolism and genome stability.
Gonfloni S; Iannizzotto V; Maiani E; Bellusci G; Ciccone S; Diederich M
Biochem Pharmacol; 2014 Nov; 92(1):149-56. PubMed ID: 25218422
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65.
Shinozaki S; Chang K; Sakai M; Shimizu N; Yamada M; Tanaka T; Nakazawa H; Ichinose F; Yamada Y; Ishigami A; Ito H; Ouchi Y; Starr ME; Saito H; Shimokado K; Stamler JS; Kaneki M
Sci Signal; 2014 Nov; 7(351):ra106. PubMed ID: 25389371
[TBL] [Abstract][Full Text] [Related]
53. Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.
Asaka R; Miyamoto T; Yamada Y; Ando H; Mvunta DH; Kobara H; Shiozawa T
Lab Invest; 2015 Dec; 95(12):1363-73. PubMed ID: 26367491
[TBL] [Abstract][Full Text] [Related]
54. Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells.
Lee SJ; Hwang SO; Noh EJ; Kim DU; Nam M; Kim JH; Nam JH; Hoe KL
Exp Mol Med; 2014 Feb; 46(2):e76. PubMed ID: 24525822
[TBL] [Abstract][Full Text] [Related]
55. Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity.
Knight JR; Allison SJ; Milner J
Open Biol; 2013 Nov; 3(11):130130. PubMed ID: 24258275
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.
Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T
RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038
[TBL] [Abstract][Full Text] [Related]
57. AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells.
Fu J; Zhang H; Zhang Y; Zhang T
Mol Cell Biochem; 2019 Apr; 454(1-2):165-175. PubMed ID: 30350304
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA‑138‑5p drives the progression of heart failure via inhibiting sirtuin 1 signaling.
Sun S; Wang C; Weng J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576462
[TBL] [Abstract][Full Text] [Related]
59. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1).
Liu X; Wang D; Zhao Y; Tu B; Zheng Z; Wang L; Wang H; Gu W; Roeder RG; Zhu WG
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1925-30. PubMed ID: 21245319
[TBL] [Abstract][Full Text] [Related]
60. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
